Our previous study found that NEK2 was highly expressed in liver cancer cells and tissues, and the overexpression of NEK2 was related to clinicopathological features and poor prognosis of patients, suggesting that NEK2 may be an important biomarker of HCC [9]. This evidence concerns the gene NEK2 and hepatocellular carcinoma.